Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |